Systemic lupus erythematosus Trials in Daegu, South Korea
Conditions / Systemic lupus erythematosus / Daegu, South Korea
Clinical trials for Systemic lupus erythematosus investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03845517 | A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) | COMPLETED | PHASE2 |
| NCT03312907 | A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE | COMPLETED | PHASE3 |
| NCT01408576 | Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus | COMPLETED | PHASE3 |
| NCT02975336 | A Phase II Study of M2951 in SLE | TERMINATED | PHASE2 |
| NCT01196091 | A Study of LY2127399 in Participants With Systemic Lupus Erythematosus | COMPLETED | PHASE3 |
| NCT01705977 | Belimumab Assessment of Safety in SLE | COMPLETED | PHASE4 |
| NCT03843125 | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) | TERMINATED | PHASE3 |
| NCT03616964 | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) | COMPLETED | PHASE3 |
| NCT01262365 | Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus | COMPLETED | PHASE3 |
| NCT03252587 | An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus | COMPLETED | PHASE2 |